This elevation was accentuated in stage IV disease patients and correlated with CEA levels but not with MSI status, which is in agreement with many previous studies demonstrating that hTERT expression and/or telomerase activity increase with tumor progression and are positively correlated with disease staging and poor differentiation, but not MSI status (6, 22, 23). The gene discussed is CEACAM5; the disease is neoplasm.